Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,458 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49,800 | 52,906 |
| Total Cites | 19,029 | 21,112 |
| H-index | 58 | 61 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 101 | 111 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2,962 | 3,308 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 5,250 | 5,843 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,557 | 14,443 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.46 |
| Self-Citation Percentage |
9.87%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,576 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53,440 | 57,165 |
| Total Cites | 16,776 | 18,604 |
| H-index | 55 | 58 |
| Hm-index | 15 | 15 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 97 | 107 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2,618 | 2,941 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 4,584 | 5,125 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,886 | 12,657 |
| Ratio of Total Citations to Distinct Citing Papers | 1.41 | 1.47 |
| Self-Citation Percentage |
9.83%
|
|
Teachey, David T.
University of Pennsylvania Perelman School of Medicine,
United States
2023 Rank: 58,624
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,728 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 58,624 | 60,426 |
| Total Cites | 14,606 | 16,228 |
| H-index | 50 | 53 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 15 | 15 |
| Total Cites to Single Authored Papers | 95 | 105 |
| Number of Single+First Authored Papers | 41 | 41 |
| Total Cites to Single+First Authored Papers | 2,316 | 2,610 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 3,925 | 4,405 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,310 | 10,990 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.48 |
| Self-Citation Percentage |
10.00%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,990 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67,302 | 72,788 |
| Total Cites | 12,089 | 13,480 |
| H-index | 44 | 45 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 85 | 94 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1,969 | 2,230 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 3,173 | 3,591 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8,528 | 9,099 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.48 |
| Self-Citation Percentage |
10.32%
|
|
Teachey, David T.
University of Pennsylvania Perelman School of Medicine,
United States
2021 Rank: 73,479
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,134 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 73,479 | 76,020 |
| Total Cites | 10,978 | 12,269 |
| H-index | 42 | 44 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 80 | 89 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 1,811 | 2,061 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 2,879 | 3,274 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7,726 | 8,254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.42 | 1.49 |
| Self-Citation Percentage |
10.52%
|
|
Teachey, David T.
University of Pennsylvania Perelman School of Medicine,
United States
2020 Rank: 94,910
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2,639 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 94,910 | 100,773 |
| Total Cites | 8,198 | 9,254 |
| H-index | 36 | 37 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 68 | 77 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 1,396 | 1,614 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 2,057 | 2,390 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5,736 | 6,168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.50 |
| Self-Citation Percentage |
11.41%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.